13D Filing: Glenview Capital and Tenet Healthcare Corp (THC)

Page 8 of 9 SEC Filing

SCHEDULE 13D
Page 8 of 9 Pages
The Reporting Persons expressly disclaim being members of a “group”, as defined in Rule 13d-5 under the Act, with the Glenview Designees.  The Reporting Persons disclaim beneficial ownership of any and all Shares owned by either of the Glenview Designees, and the Share ownership reported for the Reporting Persons does not include any Shares owned by either of the Glenview Designees.
(c) There have been no transactions in the Shares by the Reporting Persons during the past 60 days.
(d) Certain funds listed in Item 2 are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Shares covered by this Statement that may be deemed to be beneficially owned by the Reporting Persons.
(e) This Item 5(e) is not applicable.
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.
The response to Item 4 of this Schedule 13D is incorporated by reference herein.
Item 7. Material to be Filed as Exhibits.
Joint Filing Agreement
Exhibit B: Power of Attorney
Exhibit C: Support Agreement, dated January 18, 2016, by and among Glenview Capital Management and the persons and entities listed on Schedule A thereto and the Company
Exhibit D: Confidentiality Agreement, dated January 18, 2016, by and among Glenview Capital Management and the persons and entities listed on Schedule A thereto and the Company
Exhibit E: Press Release, dated January 19, 2016, issued by the Company

Follow Tenet Healthcare Corp (NYSE:THC)